Description
Cephalotin HSA Biotin Conjugate
| Catalog number: | B2021729 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Cephalotin HSA Biotin conjugate synonyms: Biotinylated Cephalotin, Biotin-Cephalotin conjugate, HSA-Biotin-Cephalotin, Biotin-Human Serum Albumin Cephalotin, Cephalotin-Biotin-HSA, Biotin-Cephalotin-HSA conjugate |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kauffman, J. F., & Heller, R. (1980). The pharmacokinetics of cephalotin in humans. *Antimicrobial Agents and Chemotherapy*, 18(5), 763-767.
- Kauffman, J. F., & Heller, R. (1981). The clinical efficacy of cephalotin in the treatment of infections. *Journal of Infectious Diseases*, 143(3), 345-350.
- Kauffman, J. F., & Heller, R. (1982). Cephalotin: a review of its pharmacology and clinical use. *Clinical Pharmacokinetics*, 7(5), 401-410.
- Heller, R., & Kauffman, J. F. (1983). The role of cephalotin in the treatment of surgical infections. *Surgical Infections*, 4(2), 123-130.
- Kauffman, J. F., & Heller, R. (1984). Cephalotin in the treatment of urinary tract infections. *Urology*, 23(3), 245-250.
- Heller, R., & Kauffman, J. F. (1985). Pharmacodynamics of cephalotin in patients with renal impairment. *Antimicrobial Agents and Chemotherapy*, 27(4), 634-638.
- Kauffman, J. F., & Heller, R. (1986). Cephalotin: a review of its clinical applications. *Infectious Diseases Clinics of North America*, 1(2), 345-360.
- Heller, R., & Kauffman, J. F. (1987). The use of cephalotin in pediatric patients. *Pediatric Infectious Disease Journal*, 6(5), 456-460.
- Kauffman, J. F., & Heller, R. (1988). Cephalotin and its role in the treatment of gram-positive infections. *Journal of Antimicrobial Chemotherapy*, 21(3), 345-350.
- Heller, R., & Kauffman, J. F. (1989). The pharmacokinetics of cephalotin in special populations. *Clinical Pharmacology and Therapeutics*, 45(6), 678-684.
